May 8 (Reuters) - Some U.S. stocks on the move on Wednesday:
Wall Street opened little changed as investors found little reason to push shares decisively one way or the other, following gains that took indexes to fresh highs a day earlier. The Dow Jones industrial average was down 0.14 percent, the Standard & Poor’s 500 Index down 0.13 percent and the Nasdaq Composite Index was down 0.11 percent.
** ALEXZA PHARMACEUTICALS, $5.62, up 30 pct (1039 ET)
** TEVA PHARMACEUTICAL INDUSTRIES, $38.86, up 1.3 pct (1038 ET)
Teva and Alexza reached an exclusive U.S. license and supply agreement for Adasuve inhalation powder for the treatment of agitation associated with schizophrenia or bipolar I disorder in adults.
** FUSION-IO INC, $13.42, down 25 pct (1028 ET)
The memory drive maker said founders David Flynn, the chief executive, and Rick White, chief marketing officer, have resigned to set up another venture.
** MARKET LEADER INC, $11.05, up 15 pct (1013 ET)
** TRULIA INC, $33.90, down 4 pct (1013 ET)
Real estate search engine company Trulia said it would buy Market Leader, which provides online technology and marketing solutions for realtors, for $355 million in a cash and stock deal. The deal represents a 18 percent premium to Market Leader’s closing price on Tuesday.
** WHOLE FOODS MARKET INC, $100.00, up 8 pct (0932 ET)
The largest U.S. natural and organic grocery chain said on Tuesday store sales have rebounded as it expands efforts to lower prices and reach beyond its core of upscale shoppers by adding more locations.
** SYMANTEC CORP, $24.00, down 4.38 pct (0934 ET)
The maker of the Norton anti-virus software on Tuesday reported a bigger-than-expected quarterly profit, but forecast first-quarter results well below analysts’ estimates due to a weak Japanese yen.
** COGNIZANT TECHNOLOGY SOLUTIONS CORP, $65.66, up 1 pct premarket
The IT services provider forecast current-quarter revenue above market expectations after an 18 percent rise in the first quarter, helped by strong demand from Europe.
** WEBMD HEALTH CORP, $30.13, up 18 pct (0935 ET)
The health information provider said on Tuesday Chief Executive Cavan Redmond will be leaving the company, less than a year after the former Pfizer Inc executive was appointed to turn around the company’s fortunes.
The company’s first-quarter net loss narrowed to 3 cents per share from a year earlier.
** VALUECLICK INC, $26.11, down 18 pct (0936 ET)
The online marketing services provider forecast second-quarter sales well below market estimates on Tuesday as it integrates its marketing, media and global service offerings.
** WENDY‘S CO, $5.83, down 5 pct (0937 ET)
The second-largest U.S. hamburger chain reported lower-than-expected quarterly sales, blaming the timing of the Easter holiday and “adverse weather conditions”.
** ING GROEP, $8.81, up 2.6 pct (0938 ET)
The Dutch banking and insurance group reported a first-quarter net profit broadly in line with forecasts, boosted by divestments, and said it plans to push ahead with the initial public offering of its European insurance unit in 2014.
** AEGON , $6.52, down 4.7 pct (1043 ET)
The Dutch insurer said first-quarter net profit fell nearly two thirds because of hedging losses resulting from an unexpectedly strong rise in U.S. stocks, particularly those in the S&P 500 index.
** ELECTRONIC ARTS INC, $20.75, up 13 pct (0957 ET)
Electronic Arts forecast fiscal 2014 earnings above Wall Street expectations as cost cuts take hold and higher-margin digital sales accelerate. Six 6 brokerages raised their price targets on the company’s stock.
** ZILLOW INC, $57.87, down 8 pct (0939 ET)
The real estate website raised its full-year revenue forecast, but said it would increase its marketing spend and that would hurt its profitability.
“Zillow’s investment in its brand advertising campaign is likely to keep EBITDA somewhat depressed going forward and this could lead to some near-term choppiness in the stock,” JMP Securities said. It, however, added that this was the right thing to do in the long term as Zillow focuses on gaining market share.
Goldman Sachs cut its rating on the company’s stock to “neutral,” the flyonthewall.com reported.
** VIVUS INC, $12.8, up 6.4 pct (1047 ET)
Vivus, under pressure from investors over the slow sales of its diet pill Qsymia, reported weak quarterly sales for the drug, but said it was in discussions with large pharmaceutical companies to expand the marketing efforts for the pill.
** DAVITA HEALTHCARE PARTNERS INC, $124.28, up 6 pct (0941 ET)
Warren Buffett’s Berkshire Hathaway Inc, the largest investor in DaVita HealthCare, has entered an agreement allowing it to nearly double its stake in the largest U.S. operator of dialysis clinics to 25 percent, according to a regulatory filing on Tuesday.
** IAMGOLD CORP, $5.87, up 9 pct (1014 ET) The Canadian miner reported a better-than-expected profit in the first quarter, largely due to lower taxes. On an adjusted basis, the company earned 15 cents per share, above the average analyst estimate of 14 cents, according to Thomson Reuters I/B/E/S.
Canaccord Genuity upgraded Iamgold shares to “buy” from “hold” on valuation.
** RESOLUTE ENERGY CORP, $8.88, down 9 pct (1023 ET) The oil and gas producer said it would offer 13.25 million shares in a public offering. Also, a few shareholders would offer another 3 million shares, the company said.
** MYRIAD GENETICS INC, $29.97, up 6 pct (0945 ET)
The company reported better-than-expected quarterly results, helped by a rise in molecular diagnostic testing revenue, and it raised its full-year earnings and profit forecast.
Mizuho Securities USA upgraded its rating on the Myriad stock to “buy” from “neutral” and raised its price target to $34 from $27.
** RUBICON TECHNOLOGY INC, $6.63, down 7.4 pct (0946 ET)
The electronic material provider on Tuesday reported a bigger-than-expected quarterly loss due to weak sales of its six-inch wafers to key customers, who had excess inventory. The company also forecast a current-quarter loss much higher than analysts’ estimates as it expects weakness in wafer sales to continue.
** C.H. ROBINSON WORLDWIDE INC, $57.16, down 7 pct (0947 ET)
The company, a third-party provider of freight transport, reported first-quarter earnings below analysts’ expectations.
Brokerages Jefferies & Co and Deutsche Bank cut their price target for the stock.
** BIOLASE INC, $4.76, down 7 pct (0951 ET)
The company, which markets lasers for dentistry and medicine, reported a larger-than-expected first-quarter loss on Tuesday, hurt by currency impact and higher expenses. (Reporting by Sruthi Ramakrishnan in Bangalore; Editing by Maju Samuel)